Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Rubicon Research Private Limited

Rubicon Research Private Limited Recalls

All product recalls associated with Rubicon Research Private Limited.

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Aug 2024

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–4 of 4 recalls

AcetaZOLAMIDE Tablets (Rubicon) – Discoloration (2024)

Discoloration

Class IIILow

FDAAug 24, 2024Nationwide• Rubicon Research Private Limited

Metoprolol Tablets (Rubicon) – Metal Contamination (2024)

Presence of Foreign Substance: metal in tablet

Class IIModerate

FDAMay 6, 2024Nationwide• Rubicon Research Private Limited

Tramadol Tablets (Rubicon) – Foreign Tablet Presence (2024)

Presence of Foreign Tablets: Pharmacist reported a tablet of baclofen in a bottle of 1000-count tramadol

Class IIModerate

FDAApr 26, 2024Nationwide• Rubicon Research Private Limited

Metoprolol Tablets (Rubicon Research) – Metal Embedded (2021)

Complaint received of foreign matter (metal) embedded in tablet.

Class IIModerate

FDADec 31, 2021Nationwide• Rubicon Research Private Limited